Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 13Phase 1/2 9Phase 3 5Phase NA 1Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia, Myeloid, Acute 11Neoplasm, Residual 3Leukemia 3Recurrence 2Leukemia, Promyelocytic, Acute 2Burkitt Lymphoma 2Myelodysplastic Syndromes 1Meningitis 1Meningeal Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Vincristine 1Methotrexate 1Hydrocortisone 1Dexamethasone 1Daunorubicin 1Cytarabine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Biphenotypic, Acute × Cytarabine × Clear all
NCT06289673 2026-05-01

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

St. Jude Children's Research Hospital

Phase 4 Recruiting
850 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡